A novel molecular modelling study of inhibitors of the 17α-hydroxylase component of the enzyme system 17α-hydroxylase/17,20-lyase (P-450 17α )

This publication has 11 references indexed in Scilit:

• The mechanism of aromatase — a molecular modelling perspective
  Bioorganic & Medicinal Chemistry Letters, 1995
• Molecular modelling of inhibitors of aromatase — a novel approach
  Bioorganic & Medicinal Chemistry Letters, 1995
• Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer
  Journal of Medicinal Chemistry, 1995
• Incorporation of label from¹⁸O₂into acetate during side-chain cleavage catalysed by cytochrome P-450_17α(17α-hydroxylase-17,20-lyase)
  Journal of the Chemical Society, Perkin Transactions 1, 1994
• Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy
  Cancer, 1993
• Inhibitors of the P450 enzymes aromatase and lyase. Crystallographic and molecular modeling studies suggest structural features of pyridylacetic acid derivatives responsible for differences in enzyme inhibitory activity
  Journal of Medicinal Chemistry, 1990
• Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid
  Journal of Medicinal Chemistry, 1990
• A molecular model for the enzyme cytochrome P45017α, a major target for the chemotherapy of prostatic cancer
  Biochemical and Biophysical Research Communications, 1990
• Structure-Activity Relationships for Non-Steroidal Inhibitors of Aromatase
  Journal of Enzyme Inhibition, 1988
• Inhibition of testicular 17α-hydroxylase and 17,20-lyase but not 3β-hydroxysteroid dehydrogenase-isomerase or 17β-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs
  The Journal of Steroid Biochemistry and Molecular Biology, 1987